Chronic pramipexole treatment increases tolerance for sucrose in normal and ventral tegmental lesioned rats.

The loss of dopamine neurons observed in Parkinson’s disease (PD) elicits severe motor control deficits which are reduced by the use of dopamine agonists. However, recent works have indicated that D3-preferential agonists such as pramipexole can induce impulse control disorders such as food craving...

Full description

Bibliographic Details
Main Authors: David eDARDOU, Carine eChassain, Franck eDurif
Format: Article
Language:English
Published: Frontiers Media S.A. 2015-01-01
Series:Frontiers in Neuroscience
Subjects:
Online Access:http://journal.frontiersin.org/Journal/10.3389/fnins.2014.00437/full
id doaj-5a80abe4ad084195bc24104c8ac7dc2e
record_format Article
spelling doaj-5a80abe4ad084195bc24104c8ac7dc2e2020-11-25T00:10:17ZengFrontiers Media S.A.Frontiers in Neuroscience1662-453X2015-01-01810.3389/fnins.2014.00437115915Chronic pramipexole treatment increases tolerance for sucrose in normal and ventral tegmental lesioned rats.David eDARDOU0Carine eChassain1Franck eDurif2Franck eDurif3Université d'Auvergne (UdA)CHU G. MontpiedUniversité d'Auvergne (UdA)CHU G. MontpiedThe loss of dopamine neurons observed in Parkinson’s disease (PD) elicits severe motor control deficits which are reduced by the use of dopamine agonists. However, recent works have indicated that D3-preferential agonists such as pramipexole can induce impulse control disorders such as food craving or compulsive eating. In the present study, we performed an intermittent daily feeding experiment to assess the effect of chronic treatment by pramipexole and VTA bilateral lesion on tolerance for sucrose solution. The impact of such chronic treatment on spontaneous locomotion and spatial memory was also examined. Changes in sucrose tolerance could indicate the potential development of a change in food compulsion or addiction related to the action of pramipexole. Neither the bilateral lesion of the VTA nor chronic treatment with pramipexole altered the spontaneous locomotion or spatial memory in rats. Rats without pramipexole treatment quickly developed a stable intake of sucrose solution in the 12h access phase. On the contrary, when under daily pramipexole treatment, rats developed a stronger and ongoing escalation of their sucrose solution intakes. In addition, we noted that the change in sucrose consumption was sustained by an increase of the expression of the dopamine 3 receptor in the core and the shell regions of the nucleus accumbens. The present results may suggest that long term stimulation of the dopamine 3 receptor in animals induces a strong increase in sucrose consumption, indicating an effect of this receptor on certain pathological aspects of food eating.http://journal.frontiersin.org/Journal/10.3389/fnins.2014.00437/fullParkinson’s diseaseSucrose toleranceventral tegmenta areadopamine agonistpramipexolefood compulsion.
collection DOAJ
language English
format Article
sources DOAJ
author David eDARDOU
Carine eChassain
Franck eDurif
Franck eDurif
spellingShingle David eDARDOU
Carine eChassain
Franck eDurif
Franck eDurif
Chronic pramipexole treatment increases tolerance for sucrose in normal and ventral tegmental lesioned rats.
Frontiers in Neuroscience
Parkinson’s disease
Sucrose tolerance
ventral tegmenta area
dopamine agonist
pramipexole
food compulsion.
author_facet David eDARDOU
Carine eChassain
Franck eDurif
Franck eDurif
author_sort David eDARDOU
title Chronic pramipexole treatment increases tolerance for sucrose in normal and ventral tegmental lesioned rats.
title_short Chronic pramipexole treatment increases tolerance for sucrose in normal and ventral tegmental lesioned rats.
title_full Chronic pramipexole treatment increases tolerance for sucrose in normal and ventral tegmental lesioned rats.
title_fullStr Chronic pramipexole treatment increases tolerance for sucrose in normal and ventral tegmental lesioned rats.
title_full_unstemmed Chronic pramipexole treatment increases tolerance for sucrose in normal and ventral tegmental lesioned rats.
title_sort chronic pramipexole treatment increases tolerance for sucrose in normal and ventral tegmental lesioned rats.
publisher Frontiers Media S.A.
series Frontiers in Neuroscience
issn 1662-453X
publishDate 2015-01-01
description The loss of dopamine neurons observed in Parkinson’s disease (PD) elicits severe motor control deficits which are reduced by the use of dopamine agonists. However, recent works have indicated that D3-preferential agonists such as pramipexole can induce impulse control disorders such as food craving or compulsive eating. In the present study, we performed an intermittent daily feeding experiment to assess the effect of chronic treatment by pramipexole and VTA bilateral lesion on tolerance for sucrose solution. The impact of such chronic treatment on spontaneous locomotion and spatial memory was also examined. Changes in sucrose tolerance could indicate the potential development of a change in food compulsion or addiction related to the action of pramipexole. Neither the bilateral lesion of the VTA nor chronic treatment with pramipexole altered the spontaneous locomotion or spatial memory in rats. Rats without pramipexole treatment quickly developed a stable intake of sucrose solution in the 12h access phase. On the contrary, when under daily pramipexole treatment, rats developed a stronger and ongoing escalation of their sucrose solution intakes. In addition, we noted that the change in sucrose consumption was sustained by an increase of the expression of the dopamine 3 receptor in the core and the shell regions of the nucleus accumbens. The present results may suggest that long term stimulation of the dopamine 3 receptor in animals induces a strong increase in sucrose consumption, indicating an effect of this receptor on certain pathological aspects of food eating.
topic Parkinson’s disease
Sucrose tolerance
ventral tegmenta area
dopamine agonist
pramipexole
food compulsion.
url http://journal.frontiersin.org/Journal/10.3389/fnins.2014.00437/full
work_keys_str_mv AT davidedardou chronicpramipexoletreatmentincreasestoleranceforsucroseinnormalandventraltegmentallesionedrats
AT carineechassain chronicpramipexoletreatmentincreasestoleranceforsucroseinnormalandventraltegmentallesionedrats
AT franckedurif chronicpramipexoletreatmentincreasestoleranceforsucroseinnormalandventraltegmentallesionedrats
AT franckedurif chronicpramipexoletreatmentincreasestoleranceforsucroseinnormalandventraltegmentallesionedrats
_version_ 1725408491702583296